SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Open-market buys and sells only — the deliberate trades. Zero here doesn’t mean no filings: grants, option exercises and tax withholding (below) are compensation, not market trades.
| Insider | Role | Date | Transaction | Shares | Value |
|---|---|---|---|---|---|
| Binns Justin T | President, Glob. Architectural | 2026-08-18 | Gift | 813 | $0 |
| Binns Justin T | President, Glob. Architectural | 2026-08-17 | Option exercise | 13500 | $1.2M |
| Binns Justin T | President, Glob. Architectural | 2026-08-17 | Open-market sell | 13500 | $4.8M |
| Jorgenrud Karl J | President, Glob. Industrial | 2026-08-07 | Option exercise | 90 | $12K |
| Jorgenrud Karl J | President, Glob. Industrial | 2026-08-07 | Open-market sell | 7886 | $2.9M |
| ANDERSON KERRII B | Director | 2026-07-06 | Grant/award | 29 | $10K |
| Gamgort Robert James | Director | 2026-07-06 | Grant/award | 96 | $34K |
| THAMAN MICHAEL H | Director | 2026-07-06 | Grant/award | 96 | $34K |
| Williams Thomas | Director | 2026-07-06 | Grant/award | 96 | $34K |
| ANDERSON KERRII B | Director | 2026-04-06 | Grant/award | 32 | $10K |
| Gamgort Robert James | Director | 2026-04-06 | Grant/award | 107 | $34K |
| THAMAN MICHAEL H | Director | 2026-04-06 | Grant/award | 107 | $34K |
| Williams Thomas | Director | 2026-04-06 | Grant/award | 107 | $34K |
| Young Bryan J | SVP - Corp Strategy & Devel. | 2026-02-24 | Open-market sell | 2513 | $916K |
| ANDERSON KERRII B | Director | 2026-02-17 | Grant/award | 558 | $0 |
| Binns Justin T | President, Glob. Architectural | 2026-02-17 | Grant/award | 9900 | $0 |
| Binns Justin T | President, Glob. Architectural | 2026-02-17 | Tax withholding | 4416 | $1.6M |
| Boyce Marlena K. | SVP - CHRO | 2026-02-17 | Grant/award | 1338 | $0 |
| Boyce Marlena K. | SVP - CHRO | 2026-02-17 | Tax withholding | 411 | $151K |
| Davie Colin M. | Pres. & GM, Glob. Supply Chain | 2026-02-17 | Grant/award | 3300 | $0 |
Fiscal period ending 2025-12-31 versus 2024-12-31 — view filing on EDGAR →
A $525M acquisition of Suvinil and a 26x acceleration in debt growth ($982.9M added year-over-year) materially elevate leverage and integration risk. New language constraining dividends and buybacks signals the balance sheet is under real pressure. The removal of a prior integration risk disclosure is offset by the fresh M&A event, leaving the net risk picture meaningfully worse.
2 company-specific · 1 eased/removed
New disclosure of material $525M Suvinil acquisition completed October 2025 and integration risk. Substantive M&A event requiring investor attention.
Our results of operations, cash flow or financial condition may be negatively impacted if we do not successfully integrate past and future acquisitions into our existing operations and if the…
Debt increased $982.9M year-over-year (vs. $37.5M prior year), a 26x acceleration. New language added about limiting shareholder returns (dividends/buybacks), escalating leverage concerns.
We require a significant amount of cash to service the substantial amount of debt we have outstanding. Our ability to generate cash depends on many factors beyond our control. We also depend on the…
Removal of acquisition integration risk disclosure suggests company no longer views M&A integration as material threat to operations or financial condition, indicating either reduced acquisition activity or improved integration capability.
Our results of operations, cash flow or financial condition may be negatively impacted if we do not successfully integrate past and future acquisitions into our existing operations and if the…
The filing discloses Sherwin-Williams' second quarter 2026 financial results via a press release dated July 28, 2026, including consolidated net sales of $6.79 billion (up 7.5%), diluted EPS of $3.43 (up 14.3%), and net income of $843.6 million. The company also raised full-year 2026 guidance. This is a standard quarterly earnings release under Item 2.02, furnished as Exhibit 99.1.
View raw filing on EDGAR →Sherwin-Williams entered into Amendment No. 11 to its credit facility, extending $200 million in credit commitments from June 2026 to June 2031. This material financing arrangement affects the company's liquidity and capital structure flexibility.
View raw filing on EDGAR →